The number of HIV-infected patients in the world is estimated at 34 million, including 30.1 million adults with 2.7 million new infections and 1.8 million deaths from HIV according to the 2011 UN AIDS report [1]. The prevalence of HIV infection in the general population of Mali is estimated at 1.1% according to DHSM-V [2]. Cardiovascular manifestations are increasingly encountered during our consultations with patients living with HIV. Thus we initiated this work with the aim of studying the cardiovascular lesions during the HIV-AIDS in the department of internal medicine of the point G. Methods: This retrospective descriptive study was conducted in the Internal Medicine department of the University Hospital Center (CHU) of the Point G from January 2008 to December 2012. Having included all HIV + patients hospitalized in the service with cardiovascular manifestations and who had performed a chest X-ray, cardiac and vascular ultrasound, electrocardiogram and/or cerebral computed tomography. Results: At the end of this work, 20 patients with cardiovascular lesions were identified in 273 hospitalized patients during the study period, i.e. a frequency of 7.3%. The 40 to 50 age group accounted for 45.0% with an average age of 42.4 ± 8.73 years. The most common cardiovascular risk factors were hypertension and active smoking with 31.58% each. Pericarditis accounted for 32% of cases, followed by cardiomyopathies with 23%. Conclusion: In our study, cardiovascular lesions are common in PHAs and etiologies are dominated by pericarditis.
References
[1]
World Day Aids (2011) Epidemiological Data. UNAIDS Report, 12 p.
[2]
(2013) Demographic and Health Survey of Mali (DHSM-V). Preliminary Report on HIV Prevalence. INFO-STAT, Planning and Statistics Unit (CPS), National Institute of Statistics (INSTAT), Bamako, and ICF International, Calverton, 16 p.
[3]
Hoen, B. (2007) Role of HIV in Bone, Cardiovascular and Renal Complications. In: Hoen, B., Martin, I.P. and Boccara, F., Eds., Medicine and Infectious Diseases, Vol. 37, Elsevier, France, 1-12.
[4]
Kwong, G.P.S., Azra, C.G., Rode, R.A., Bartley, L.M., Cowling, B.J., Da Silva, B., et al. (2006) Comparison of the Risks of Atherosclerotic Events versus Death from Others Causes Associated with Antiretroviral Use. AIDS, 20, 1942-1950. https://doi.org/10.1097/01.aids.0000247115.81832.a1
[5]
Laurence, J. (1998) Vascular Complications Associated with the Use of HIV Protease Inhibitors. The Lancet, 351, 1960. https://doi.org/10.1016/S0140-6736(05)78645-1
[6]
Bergersen, B.M., Sandvik, L., Bruun, J.N. and Tonstad, S. (2004) Elevated Framingham Risk Score in HIV-Positive Patients on Highly Active Antiretroviral Therapy: Results from a Norwegian Study of 721 Subjects. European Journal of Clinical Microbiology & Infectious Diseases, 23, 625-630. https://doi.org/10.1007/s10096-004-1177-6
[7]
Knudsen, A. (2013) Angiographic Features and Cardiovascular Risk Factors in Human Immunodeficiency Virus-Infected Patients with First-Time Acute Coronary Syndrome. American Journal of Cardiology, 111, 63-67. https://doi.org/10.1016/j.amjcard.2012.08.047
[8]
Jerome, A. (2007) Cardiovascular Complications of the HIV-Infected Subject. Synthesis of the Literature Descriptive Study within a Population Followed at the University Hospital of Saint-Germainen-Lay. Med. These, 92 p.
[9]
Niakara, A., Drabo, Y.J., Kambire, Y., Nebie, L.V.A., Kabore, N.J.P. and Simon, F. (2002) Cardiovascular Disease and HIV Infection: A Study of 79 Cases at the CHN of Ouagadougou (Burkina Faso). Bulletin de la Société de Pathologie Exotique, 95, 23-26.
[10]
Anzouan-Kacou, J.B., Dogoua, P., Konin, C., Coulibaly, I., Ouattara, I., Eholie, S.P., et al. (2012) Cardiovascular Disorders in HIV-Positive Patients Not Treated with Antiretrovirals. Tropical Cardiology, 131, 22 p.
[11]
Mouanodji, M. (1996) Clinical Profile of 55 AIDS Patients with Cardiac Manifestations in Africa: Experiments at the N’djamena Central Hospital (Chad). African’s Black Medicine, 43, 273-278.
[12]
Diarra, A. (2000) Prevalence of Cardiovascular Diseases during AIDS in the Cardiology Departments of Gabriel Touré and G-Spot Hospitals; about 132 Cases. Med. These, Bko, 40 p.
[13]
Bennis, A., Mehadji, B., Nourredine, M., et al. (1995) Cardiac Tamponade in the Acquired Immunodeficiency Syndrome. Tropical Cardiology, 21, 87-90.
[14]
Bouramoue, C. and Ekoba, J. (1996) Heart and AIDS. Tropical Medicine, 56, 33-39.
[15]
Sidibé, S. (2007) Pericarditis during HIV Infection in Bamako. These, Med, Bko, N64.
[16]
Nzuobontane, D., Blackett, K.N. and Kuaban, C. (2002) Cardiac Involvement in HIV Infected People in Yaounde, Cameroon. Postgraduate Medical Journal, 78, 678-681. https://doi.org/10.1136/pmj.78.925.678
[17]
Ovbiagele, B. (2011) Increasing Incidence of Ischemic Stroke in Patients with HIV Infection. Neurology, 76, 444-450. https://doi.org/10.1212/WNL.0b013e31820a0cfc
[18]
Lijfering, W.M., Sprenger, H.G., Georg, R.R., Van Der Meulen, P.A. and Van Der Meer, J. (2008) Relationship between AIDS and Thrombophilic Abnormalities in HIV Infection. Clinical Chemistry, 54, 1226-1233. https://doi.org/10.1373/clinchem.2008.103614
[19]
Jaquet, A., Bissagnene, E., Ekouevi, D.K., Traore, A., abubakrine, M., Maiga, M., et al. (2009) Tobacco Use and Its Determinants in HIV-Infected Patients on Antiretroviral Therapy in West African Countries. International Journal of Tuberculosis and Lung Disease, 13, 1433-1439.
